智通财经APP获悉，百奥赛图-B(02315)午后涨超8%，截至发稿，涨6.28%，报53.3港元，成交额5248.07万港元。
消息面上，近日，百奥赛图与Whitehawk Therapeutics达成一项全球战略合作协议，涵盖多个双特异性抗体偶联药物（BsADC）研发项目，双方将共同推进新一代治疗产品管线。从正式启动合作到完成协议签署，仅历时约四个月，推进速度远快于行业同类项目。
据悉，Whitehawk将对百奥赛图提供的五款双特异性抗体进行评估，并有权选择将任何由此产生的ADC候选药物推进至其研发管线中，百奥赛图将获得一定数额的首付款及潜在里程碑付款。Whitehawk CEO表示，公司预计在未来12至24个月内提交新的ADC临床试验申请（IND）。
更多港股重磅资讯，下载智通财经app
更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.